Michael Handley

Michael Handley

Directeur/Membre du Conseil chez VALION BIO, INC.

Fortune : 1 574 $ au 31/08/2026

55 ans
Health Technology
Consumer Services
Commercial Services

Profil

Mr. Michael K.
Handley is a Chairman, President & Chief Executive Officer at Sparta Healthcare Acquisition Corp.
and a Chief Executive Officer at Aletheia Therapeutics, Inc. He is on the Board of Directors at PetVivo Holdings, Inc., Valion Bio, Inc., Aletheia Therapeutics Corp., Makamer Holdings, Inc., Makamer, Inc. and Reven Holdings, Inc. Mr. Handley was previously employed as a President, Chief Executive Officer & Director by Cleveland BioLabs, Inc., a Chairman, President & Chief Executive Officer by Statera Biopharma, Inc., a President, Chief Executive Officer & Director by Cytocom, Inc. /Old/, a President, Chief Executive Officer & Director by Immune Therapeutics, Inc., a Chief Executive Officer & Director by Marizyme, Inc., a Chairman by Medavate Corp., a Chief Executive Officer & Director by Armis Biopharma, Inc., a Vice President-Regulatory, Clinical & Quality by Vessix Vascular, Inc., a Global Head-Regulatory by Acclarent, Inc., a Chief Compliance Officer & VP-Regulatory by The Spectranetics Corp., a CEO, VP-Regulatory, Business Development & Quality by AccelaPure Corp., and a Senior Principal by PRTM Management Consultants LLC.
He also served on the board at Coeptis Therapeutics, Inc. He received his undergraduate degree from Colorado State University and an MBA from Pepperdine Graziadio Business School.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
30/06/2026 441 ( 0,03% ) 1 574 $ 31/08/2026

Postes actifs de Michael Handley

SociétésPosteDébut
HOMETOWN INTERNATIONAL, INC. Directeur/Membre du Conseil -
VALION BIO, INC. Directeur/Membre du Conseil 03/03/2026
PETVIVO HOLDINGS, INC. Directeur/Membre du Conseil 22/09/2026
Directeur Général 01/01/2021
Directeur/Membre du Conseil -
Directeur Général -
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -

Anciens postes connus de Michael Handley

SociétésPosteFin
STATERA BIOPHARMA, INC. Directeur Général 01/02/2025
░░░░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Michael Handley

Formation de Michael Handley

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

59

Relations au 1er degré

23

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées23

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Retail Trade

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Finance

Health Technology

Process Industries

  1. Bourse
  2. Insiders
  3. Michael Handley